| First Author | Sleigh JN | Year | 2020 |
| Journal | Cell Rep | Volume | 30 |
| Issue | 11 | Pages | 3655-3662.e2 |
| PubMed ID | 32187538 | Mgi Jnum | J:287650 |
| Mgi Id | MGI:6416804 | Doi | 10.1016/j.celrep.2020.02.078 |
| Citation | Sleigh JN, et al. (2020) Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes. Cell Rep 30(11):3655-3662.e2 |
| abstractText | Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disease resulting from a complex interplay between genetics and environment. Impairments in axonal transport have been identified in several ALS models, but in vivo evidence remains limited, thus their pathogenetic importance remains to be fully resolved. We therefore analyzed the in vivo dynamics of retrogradely transported, neurotrophin-containing signaling endosomes in nerve axons of two ALS mouse models with mutations in the RNA processing genes TARDBP and FUS. TDP-43(M337V) mice, which show neuromuscular pathology without motor neuron loss, display axonal transport perturbations manifesting between 1.5 and 3 months and preceding symptom onset. Contrastingly, despite 20% motor neuron loss, transport remained largely unaffected in Fus(Delta14/+) mice. Deficiencies in retrograde axonal transport of signaling endosomes are therefore not shared by all ALS-linked genes, indicating that there are mechanistic distinctions in the pathogenesis of ALS caused by mutations in different RNA processing genes. |
